Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Clear the Shelters: WRAL, NBC and local animal shelters pet adoption month
Recommended
Parents want more warnings after a brain-eating amoeba killed their son on a South Carolina lake
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by SOLVE FSHD
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
June 08, 2025
From
SOLVE FSHD
Via
Business Wire
SOLVE FSHD Announces $3 Million Investment in Armatus Bio to Advance Gene Therapy Program for FSHD
May 06, 2025
From
SOLVE FSHD
Via
Business Wire
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
March 25, 2025
From
SOLVE FSHD
Via
Business Wire
SOLVE FSHD Challenges Innovators with USD$10 Million Bonus Prize to Accelerate FSHD Breakthroughs in XPRIZE Healthspan Competition
December 05, 2024
From
SOLVE FSHD
Via
Business Wire
SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
July 11, 2023
From
Solve FSHD
Via
GlobeNewswire
SOLVE FSHD invests in Epic Bio for the development of a novel treatment for Facioscapulohumeral Muscular Dystrophy
April 18, 2023
From
Solve FSHD
Via
GlobeNewswire
CORRECTION -- SOLVE FSHD invests US$10 Million in Vita Therapeutics
October 13, 2022
From
Solve FSHD
Via
GlobeNewswire
SOLVE FSHD invests US$10 Million in Vita Therapeutics
October 13, 2022
From
Solve FSHD
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.